Systematic review: The costs of ulcerative colitis in Western countries

Alimentary Pharmacology and Therapeutics

Volumn 31, Issue 7, 2010, Pages 693-707

  Cohen, R D ^a   Yu, A P ^b   Wu, E Q ^b   Xie, J ^b   Mulani, P M ^c   Chao, J ^c  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^b ANALYSIS GROUP   (United States)

^c ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABSENTEEISM; CANADA; COLON RESECTION; COST BENEFIT ANALYSIS; CROHN DISEASE; DISEASE SEVERITY; ECONOMIC ASPECT; EMBASE; EMERGENCY WARD; EUROPE; GEOGRAPHY; GERMANY; HEALTH CARE COST; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; ISRAEL; ITALY; LENGTH OF STAY; MEDICAL EXAMINATION; MEDICAL LEAVE; MEDICAL RECORD; MEDLINE; PRIORITY JOURNAL; PRODUCTIVITY; REMISSION; RETIREMENT; REVIEW; SPAIN; SWEDEN; SYSTEMATIC REVIEW; ULCERATIVE COLITIS; UNEMPLOYMENT; UNITED KINGDOM; UNITED STATES; COST OF ILLNESS; ECONOMICS;

CANADA; COLITIS, ULCERATIVE; COST OF ILLNESS; EUROPE; HOSPITALIZATION; HUMANS; UNITED STATES;

EID: 77649231105     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2010.04234.x     Document Type: Review

References (52)

1. Tindall WN, Boltri JM, Wilhelm SM. Mild-to-moderate ulcerative colitis: your role in patient compliance and health care costs. J Manag Care Pharm 2007 13 (7 Suppl A S2 12.
2. Loftus CG, Loftus EV Jr., Harmsen WS, et al. Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940-2000. Inflamm Bowel Dis 2007 13 : 254 261.
3. Kappelman MD, Rifas-Shiman SL, Kleinman K, et al. The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol 2007 5 : 1424 1429.
4. Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 2004 126 : 1504 1517.
5. Lakatos L, Lakatos PL. Is the incidence and prevalence of inflammatory bowel diseases increasing in Eastern Europe? Postgrad Med J 2006 82 : 332 337. (Pubitemid 43780664)
6. Holtmann MH, Galle PR. Current concept of pathophysiological understanding and natural course of ulcerative colitis. Langenbecks Arch Surg 2004 389 : 341 349.
7. Langholz E, Munkholm P, Davidsen M, Nielsen OH, Binder V. Changes in extent of ulcerative colitis: a study on the course and prognostic factors. Scand J Gastroenterol 1996 31 : 260 266.
8. Farmer RG, Easley KA, Rankin GB. Clinical patterns, natural history, and progression of ulcerative colitis. A long-term follow-up of 1116 patients. Dig Dis Sci 1993 38 : 1137 1146.
9. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001 48 : 526 535.
10. Bodger K. Cost of illness of Crohn's disease. Pharmacoeconomics 2002 20 : 639 652.
11. Yu AP, Cabanilla LA, Wu EQ, Mulani PM, Chao J. The costs of Crohn's disease in the United States and other Western countries: a systematic review. Curr Med Res Opin 2008 24 : 319 328.
12. Department of Health and Human Services, Centers for Medicare & Medicaid. Proposed Changes to the Hospital Inpatient Prospective Payment Systems and Fiscal Year 2009 Rates. Available at: http://edocket.access.gpo.gov/2008/ pdf/08-1135.pdf. Accessed November 3, 2009.
13. United States Bureau of Labor Statistics. Consumer price index: current series. Available at: http://www.bls.gov/data/. Accessed July 31, 2008.
14. Martin A, Gurrieri G, Sturniolo GC, Naccarato R. Follow-up of ulcerative colitis, Crohn's disease, gallstones and chronic active liver disease: analysis of costs. Ital J Gastroenterol 1985 17 : 11 3.
15. Bank EC. Fixed Euro conversion rates. Available at: http://www.ecb.int/ bc/intro/html/index.en.html. Accessed September 6, 2007.
16. The American Gastroenterological Association. The Burden of Gastrointestinal Disease. Bethesda, MD, 2001. Available at: http://www.gastro. org/user-assets/Documents/burden-report.pdf. Accessed May 22, 2009.
17. Hillson E, Dybicz S, Waters HC, et al. Health care expenditure in ulcerative colitis: the perspective of a self-insured employer. J Occup Environ Med 2008 50 : 969 977.
18. Gibson TB, Ng E, Ozminkowski RJ, et al. The direct and indirect cost burden of Crohn's disease and ulcerative colitis. J Occup Environ Med 2008 50 : 1261 1272.
19. Kappelman MD, Rifas-SHiman SL, Porter CQ, et al. Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults. Gastroenterology 2008 135 : 1907 1913.
20. Bickston SJ, Waters HC, Dabbous O, Tang BI, Rahman M. Administrative claims analysis of all-cause annual costs of care and resource utilization by age category for ulcerative colitis patients. J Manag Care Pharm 2008 14 : 352 362.
21. Hay JW, Hay AR. Inflammatory bowel disease: costs-of-illness. J Clin Gastroenterol 1992 14 : 309 317.
22. Hay AR, Hay JW. Inflammatory bowel disease: medical cost algorithms. J Clin Gastroenterol 1992 14 : 318 327.
23. Pinchbeck BR, Kirdeikis J, Thomson ABR. Economic impact of inflammatory bowel disease in Alberta. Can J Gastroenterol 1988 2 : 53 6.
24. Bassi A, Dodd S, Williamson P, Bodger K. Cost of illness of inflammatory bowel disease in the UK: a single centre retrospective study. Gut 2004 53 : 1471 1478.
25. Stark R, Konig HH, Leidl R. Costs of inflammatory bowel disease in Germany. Pharmacoeconomics 2006 24 : 797 814.
26. Odes S, Vardi H, Friger M, et al. Cost analysis and cost determinants in a European inflammatory bowel disease inception cohort with 10 years of follow-up evaluation. Gastroenterology 2006 131 : 719 728.
27. D'Haens G, Sandborn WJ, Feagan BG, et al. A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis. Gastroenterology 2007 132 : 763 786.
28. Loftus EV, Friedman HS, Delgado DJ, Sandborn WJ. Colectomy subtypes, follow-up surgical procedures, postsurgical complications, and medical charges among ulcerative colitis patients with private health insurance in the United States. Inflamm Bowel Dis 2009 15 : 566 575.
29. Panes J, Guilera M, Ginard D, et al. Treatment cost of ulcerative colitis is apheresis with Adacolumn cost-effective? Dig Liver Dis 2007 39 : 617 625.
30. Ebinger M, Leidl R, Thomas S, et al. Cost of outpatient care in patients with inflammatory bowel disease in a German University Hospital. J Gastroenterol Hepatol 2004 19 : 192 199.
31. Mackowiak JI. A two-stage decision analysis to assess the cost of 5-aminosalicylic acid failure and the economics of balsalazide versus mesalamine in the treatment of ulcerative colitis. Manag Care Interface 2006 19 : 39 46, 56.
32. Sher ME, Weiss EG, Nogueras JJ, Wexner SD. Morbidity of medical therapy for ulcerative colitis: what are we really saving? Int J Colorectal Dis 1996 11 : 287 293.
33. Nguyen GC, Tuskey A, Dassopoulos T, Harris ML, Brant SR. Rising hospitalization rates for inflammatory bowel disease in the United States between 1998 and 2004. Inflamm Bowel Dis 2007 13 : 1529 1535.
34. Milenkovic M, Russo A, Elixhauser A. Hospital Stays for Gastrointestinal Diseases, 2004. Agency for Healthcare Research and Quality, 2006 Available at: http://www.hcup-us.ahrq.gov/reports/statbriefs/sb12.pdf. Accessed May 22, 2009.
35. Ananthakrishnan AN, McGinley EL, Binion DG. Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease. Gut 2008 57 : 205 210.
36. Bernstein CN, Papineau N, Zajaczkowski J, Rawsthorne P, Okrusko G, Blanchard JF. Direct hospital costs for patients with inflammatory bowel disease in a Canadian tertiary care university hospital. Am J Gastroenterol 2000 95 : 677 683.
37. Swenson BR, Hollenbeak CS, Poritz LS, Koltun WA. Modified two-stage ileal pouch-anal anastomosis: equivalent outcomes with less resource utilization. Dis Colon Rectum 2005 48 : 256 261.
38. Swenson BR, Hollenbeak CS, Koltun WA. Factors affecting cost and length of stay associated with the ileal pouch-anal anastomosis. Dis Colon Rectum 2003 46 : 754 761.
39. Archer SB, Burnett RJ, Flesch LV, et al. Implementation of a clinical pathway decreases length of stay and hospital charges for patients undergoing total colectomy and ileal pouch/anal anastomosis. Surgery 1997 122 : 699 703.
40. Cohen RD, Brodsky AL, Hanauer SB. A comparison of the quality of life in patients with severe ulcerative colitis after total colectomy versus medical treatment with intravenous cyclosporin. Inflamm Bowel Dis 1999 5 : 1 10.
41. Drossman DA, Leserman J, Mitchell CM, Li ZM, Zagami EA, Patrick DL. Health status and health care use in persons with inflammatory bowel disease. A national sample. Dig Dis Sci 1991 36 : 1746 1755.
42. Frieri G, Pimpo M, Galletti B, et al. Long-term oral plus topical mesalazine in frequently relapsing ulcerative colitis. Dig Liver Dis 2005 37 : 92 6.
43. Leijonmarck CE, Persson PG, Hellers G. Factors affecting colectomy rate in ulcerative colitis: an epidemiologic study. Gut 1990 31 : 329 333.
44. Longobardi T, Jacobs P, Bernstein CN. Work losses related to inflammatory bowel disease in the United States: results from the National Health Interview Survey. Am J Gastroenterol 2003 98 : 1064 1072. (Pubitemid 36733768)
45. Longobardi T, Jacobs P, Wu L, Bernstein CN. Work losses related to inflammatory bowel disease in Canada: results from a National Population Health Survey. Am J Gastroenterol 2003 98 : 844 849. (Pubitemid 36576312)
46. Blomqvist P, Ekbom A. Inflammatory bowel diseases: health care and costs in Sweden in 1994. Scand J Gastroenterol 1997 32 : 1134 1139.
47. United States Census Bureau. State and country quick facts. Available at: http://factfinder.census.gov/servlet/QTTable?-bm=y&-qr-name=PEP-2008-EST- DP1&-geo-id=01000US&-ds-name=PEP-2008-EST&-lang=en&-format= &-CONTEXT=qt. Accessed November 3, 2009.
48. Eurostat. Population statistics in Europe 2008: first results. Available at: http://epp.eurostat.ec.europa.eu/cache/ITY-OFFPUB/KS-QA-09-031/EN/KS-QA-09- 031-EN.PDF. Accessed November 3, 2009.
49. Joyce AT, Smith P, Khandker R, Melin JM, Singh A. Hidden cost of rheumatoid arthritis (RA): estimating cost of comorbid cardiovascular disease and depression among patients with RA. J Rheumatol 2009 36 : 743 752.
50. Levy RL, von Korff M, Whitehead WE. Cost of care for irritable bowel syndrome patients in a health maintenance organization. Am J Gastroenterol 2001 96 : 3122 3129.
51. Ferguson A, Sedgwick DM, Drummond J. Morbidity of juvenile onset inflammatory bowel disease: effects on education and employment in early adult life. Gut 1994 35 : 665 668. (Pubitemid 24163795)
52. Marri SR, Buchman AL. The education and employment status of patients with inflammatory bowel diseases. Inflamm Bowel Dis 2005 11 : 171 177.